These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis. Hodsman A; ; Papaioannou A; ; Ann Cranney ; CMAJ; 2006 Jul; 175(1):48. PubMed ID: 16818909 [No Abstract] [Full Text] [Related]
23. Corticosteroids: no drug prevention of fractures needed. Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563 [TBL] [Abstract][Full Text] [Related]
24. A case of teriparatide-induced severe hypophosphatemia and hypercalcemia. Hajime M; Okada Y; Mori H; Tanaka Y J Bone Miner Metab; 2014 Sep; 32(5):601-4. PubMed ID: 24553859 [TBL] [Abstract][Full Text] [Related]
25. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Brixen KT; Christensen PM; Ejersted C; Langdahl BL Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497 [TBL] [Abstract][Full Text] [Related]
26. [Calcium and vitamin D can prevent fractures in postmenopausal women]. Astrup AV; Michaelsen KF Ugeskr Laeger; 1993 Nov; 155(44):3579-80. PubMed ID: 8236584 [No Abstract] [Full Text] [Related]
28. Preventing osteoporosis-related fractures: an overview. Gass M; Dawson-Hughes B Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939 [TBL] [Abstract][Full Text] [Related]
29. Coming to grips with bone loss. Marx J Science; 2004 Sep; 305(5689):1420-2. PubMed ID: 15353792 [No Abstract] [Full Text] [Related]
30. Teriparatide for severe osteoporosis. Cappuzzo KA; Delafuente JC Ann Pharmacother; 2004 Feb; 38(2):294-302. PubMed ID: 14742769 [TBL] [Abstract][Full Text] [Related]
31. Calcium and vitamin D in preventing fractures: vitamin K supplementation has powerful effect. Radecki TE BMJ; 2005 Jul; 331(7508):108; author reply 109. PubMed ID: 16002893 [No Abstract] [Full Text] [Related]
32. Management of corticosteroid-induced osteoporosis. Drug Ther Bull; 2010 Sep; 48(9):98-101. PubMed ID: 20810708 [TBL] [Abstract][Full Text] [Related]
33. Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. Cosman F; Wermers RA; Recknor C; Mauck KF; Xie L; Glass EV; Krege JH J Clin Endocrinol Metab; 2009 Oct; 94(10):3772-80. PubMed ID: 19584192 [TBL] [Abstract][Full Text] [Related]
34. Osteoporosis. Information from your family doctor. American Academy of Family Physicians Am Fam Physician; 2009 Feb; 79(3):201-2. PubMed ID: 19202967 [No Abstract] [Full Text] [Related]
35. [Requirement of 25-hydroxyvitamin D in prevention of osteoporosis based on a pathophysiological perspective]. Tsugawa N Clin Calcium; 2006 Jul; 16(7):1189-94. PubMed ID: 16816480 [TBL] [Abstract][Full Text] [Related]
36. Indications to teriparatide treatment in patients with osteoporosis. Rizzoli R; Kraenzlin M; Krieg MA; Mellinghoff HU; Lamy O; Lippuner K Swiss Med Wkly; 2011; 141():w13297. PubMed ID: 22057669 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744 [TBL] [Abstract][Full Text] [Related]
38. Prevention of low-trauma fractures in older people. Scharla S Lancet; 2005 Aug 13-19; 366(9485):543; author reply 543-4. PubMed ID: 16099282 [No Abstract] [Full Text] [Related]